射血分数保留且利钠肽水平正常的心力衰竭:一项前瞻性临床与心脏MRI研究
这项前瞻性队列研究纳入疑似射血分数保留的心力衰竭(HFpEF)患者,分为易感HFpEF组(HFA-PEFF评分4分、利钠肽正常)、HFpEF组(HFA-PEFF评分≥5分)及无症状对照组,比较临床与心脏MRI特征及预后。易感HFpEF组较对照组左室重构和功能更差、全身炎症更高;较HFpEF组更年轻、血浆容量更高、房颤患病率更低、左房容积指数更低、左室整体纵向应变及早期舒张整体纵向应变率受损更轻,但预后相似。
要点
- 易感HFpEF组左室整体纵向应变为-12.2%±2.8,HFpEF组为-13.9%±3.1(P<.001)。
- 易感HFpEF组早期舒张整体纵向应变率为0.52/秒±0.20,HFpEF组为0.57/秒±0.15(P=.03)。
- 易感HFpEF组中房颤发生(HR=3.90;P=.009)、血红蛋白水平(HR=0.94;P=.001)和eGLSR(每增加0.2/秒,HR=0.28;P=.002)与主要终点独立相关。
核心结论
- 易感HFpEF患者表现出相对独特的临床和心脏MRI特征,值得更多临床关注;eGLSR应被视为易感HFpEF患者的预后因素。
研究设计与样本
- 前瞻性队列研究(MISSION-HFpEF的一部分;NCT04603404),2019年1月1日至2021年9月30日开展,纳入疑似HFpEF并接受心脏MRI者,排除原发性心肌病和原发性瓣膜性心脏病。
关键影像表现/征象
- 与对照组相比,易感HFpEF组左室重构和功能更差,全身炎症更高。
- 与HFpEF组相比,易感HFpEF组(无论是否肥胖)更年轻、血浆容量更高、房颤患病率更低、左房容积指数更低。
- 与HFpEF组相比,易感HFpEF组左室整体纵向应变受损更轻(-12.2%±2.8 vs -13.9%±3.1;P<.001)。
- 与HFpEF组相比,易感HFpEF组早期舒张整体纵向应变率受损更轻(0.52/秒±0.20 vs 0.57/秒±0.15;P=.03)。
诊断标准与关键数值
- 易感HFpEF定义为基于最新欧洲心脏病学会指南HFA-PEFF评分为4分且利钠肽水平正常的HFpEF。
- HFpEF组定义为HFA-PEFF评分≥5分。
临床应用与阅片要点
- 在疑似HFpEF且利钠肽正常的人群中,可关注HFA-PEFF评分4分这一易感群体。
- 心脏MRI评估的左室整体纵向应变和早期舒张整体纵向应变率有助于区分易感HFpEF与HFpEF。
- 在易感HFpEF患者中,eGLSR应被视为预后因素。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Purpose To describe the clinical presentation, comprehensive cardiac MRI characteristics, and prognosis of individuals with predisposed heart failure with preserved ejection fraction (HFpEF). Materials and Methods This prospective cohort study (part of MISSION-HFpEF [Multimodality Imaging in the Screening, Diagnosis, and Risk Stratification of HFpEF]; NCT04603404) was conducted from January 1, 2019, to September 30, 2021, and included individuals with suspected HFpEF who underwent cardiac MRI. Participants who had primary cardiomyopathy and primary valvular heart disease were excluded. Participants were split into a predisposed HFpEF group, defined as HFpEF with normal natriuretic peptide levels based on an HFA-PEFF (Heart Failure Association Pretest Assessment, Echocardiography and Natriuretic Peptide, Functional Testing, and Final Etiology) score of 4 from the latest European Society of Cardiology guidelines, and an HFpEF group (HFA-PEFF score of ≥ 5). An asymptomatic control group without heart failure was also included. Clinical and cardiac MRI-based characteristics and outcomes were compared between groups. The primary end points were death, heart failure hospitalization, or stroke. Results A total of 213 participants with HFpEF, 151 participants with predisposed HFpEF, and 100 participants in the control group were analyzed. Compared with the control group, participants with predisposed HFpEF had worse left ventricular remodeling and function and higher systemic inflammation. Compared with participants with HFpEF, those with predisposed HFpEF, whether obese or not, were younger and had higher plasma volume, lower prevalence of atrial fibrillation, lower left atrial volume index, and less impaired left ventricular global longitudinal strain (-12.2% ± 2.8 vs -13.9% ± 3.1; P < .001) and early-diastolic global longitudinal strain rate (eGLSR, 0.52/sec ± 0.20 vs 0.57/sec ± 0.15; P = .03) but similar prognosis. Atrial fibrillation occurrence (hazard ratio [HR] = 3.90; P = .009), hemoglobin level (HR = 0.94; P = .001), and eGLSR (per 0.2-per-second increase, HR = 0.28; P = .002) were independently associated with occurrence of primary end points in participants with predisposed HFpEF. Conclusion Participants with predisposed HFpEF showed relatively unique clinical and cardiac MRI features, warranting greater clinical attention. eGLSR should be considered as a prognostic factor in participants with predisposed HFpEF. Keywords: Heart Failure with Preserved Ejection Fraction, Normal Natriuretic Peptide Levels, Cardiovascular Magnetic Resonance, Myocardial Strain, Prognosis Clinical trial registration no. NCT04603404 Supplemental material is available for this article. © RSNA, 2024.
引用
- He J, Yang W, Wu W, et al. Heart Failure with Normal Natriuretic Peptide Levels and Preserved Ejection Fraction: A Prospective Clinical and Cardiac MRI Study. Radiol Cardiothorac Imaging. 2024. PMID: 38695743. doi:10.1148/ryct.230281
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。